Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Shiff

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Biochemical Pharmacology|December 31, 1997
Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cellsL Qiao, R Hanif, E Sphicas, et al.
Biochemical and Biophysical Research Communications|May 16, 1995
Expression of cytochrome P450 mRNAs in the colon and the rectum in normal human subjectsM G Mercurio, S J Shiff, R A Galbraith, et al.
International Journal of Cancer|January 11, 2000
Altered gastric epithelial cell kinetics in Helicobacter pylori-associated intestinal metaplasia: implications for gastric carcinogenesisI A Scotiniotis, T Rokkas, E E Furth, et al.
Biochimica Et Biophysica Acta|May 20, 1996
The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cellsC Bortuzzo, R Hanif, K Kashfi, et al.
Cancer Letters|October 1, 1996
Staurosporine inhibits the proliferation, alters the cell cycle distribution and induces apoptosis in HT-29 human colon adenocarcinoma cellsL Qiao, M Koutsos, L L Tsai, et al.
Biochimica Et Biophysica Acta|September 14, 1995
Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivoL Qiao, V Kozoni, G J Tsioulias, et al.
Oncogene|February 15, 1996
The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteinsY Goldberg, I I Nassif, A Pittas, et al.
Neurogastroenterology and Motility|January 3, 2014
Responders vs clinical response: a critical analysis of data from linaclotide phase 3 clinical trials in IBS-CB E Lacy, A J Lembo, J E Macdougall, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 12, 2000
Sulindac inhibits neointimal formation after arterial injury in wild-type and apolipoprotein E-deficient miceE D Reis, M Roque, H Dansky, et al.
Alimentary Pharmacology & Therapeutics|November 3, 2012
Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpointsE M M Quigley, J Tack, W D Chey, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Biochemical Pharmacology|December 31, 1997
Effect of aspirin on induction of apoptosis in HT-29 human colon adenocarcinoma cellsL Qiao, R Hanif, E Sphicas, et al.
Biochemical and Biophysical Research Communications|May 16, 1995
Expression of cytochrome P450 mRNAs in the colon and the rectum in normal human subjectsM G Mercurio, S J Shiff, R A Galbraith, et al.
International Journal of Cancer|January 11, 2000
Altered gastric epithelial cell kinetics in Helicobacter pylori-associated intestinal metaplasia: implications for gastric carcinogenesisI A Scotiniotis, T Rokkas, E E Furth, et al.
Biochimica Et Biophysica Acta|May 20, 1996
The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cellsC Bortuzzo, R Hanif, K Kashfi, et al.
Cancer Letters|October 1, 1996
Staurosporine inhibits the proliferation, alters the cell cycle distribution and induces apoptosis in HT-29 human colon adenocarcinoma cellsL Qiao, M Koutsos, L L Tsai, et al.
Biochimica Et Biophysica Acta|September 14, 1995
Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivoL Qiao, V Kozoni, G J Tsioulias, et al.
Oncogene|February 15, 1996
The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteinsY Goldberg, I I Nassif, A Pittas, et al.
Neurogastroenterology and Motility|January 3, 2014
Responders vs clinical response: a critical analysis of data from linaclotide phase 3 clinical trials in IBS-CB E Lacy, A J Lembo, J E Macdougall, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 12, 2000
Sulindac inhibits neointimal formation after arterial injury in wild-type and apolipoprotein E-deficient miceE D Reis, M Roque, H Dansky, et al.
Alimentary Pharmacology & Therapeutics|November 3, 2012
Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpointsE M M Quigley, J Tack, W D Chey, et al.
Pageof 3